Lucid Diagnostics Inc. (LUCD)
Lucid Diagnostics Inc. is a commercial-stage medical technology firm focused on diagnostic solutions. The company's primary objective is to serve patients afflicted with gastroesophageal reflux disease (GERD), commonly referred to as chronic heartburn or acid reflux, especially those at increased risk of developing precancerous esophageal conditions or the particularly aggressive esophageal adenocarcinoma. Their key product offerings include EsoGuard, an internally developed esophageal DNA test, and EsoCheck, a specialized device designed for collecting esophageal cells. Formed in 2018, Lucid Diagnostics Inc. has its headquarters in New York, New York, and operates as a subsidiary of PAVmed Inc.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
Lucid Diagnostics Inc.
NASDAQ:LUCDHealthcare · Medical - Devices
-6.36%$0.4048
AH$0.4038-0.25%vs close
Mkt Cap$82.27M
Float–
O/S203.24M
Vol
$ Vol
RVOL
Inst Own30.2%
Earnings
Dilution
Financials Summary
Revenue$4.71M
Net Income-$58.01M
Total Assets$40.45M
Free Cash Flow-$46.48M
Debt & Equity
Debt 28%
Equity 12%
Preferred 60%
Total Debt$25.82M
Total Equity$10.94M
Preferred Stock$54.27M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in LUCD's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$40.45M
Liabilities$29.51M
Accounts Receivable$643K
Accounts Payable$970K
Inventory$353K
PP&E (Net)$2.62M
Goodwill$0
Intangible Assets$315K
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Revenue | $4.71M | $4.35M | $2.43M | $377K | $500K | $0 | $0 | $0 |
| YoY Growth | 8.3% | 79.0% | 544.0% | -24.6% | - | - | - | - |
| Cost of Revenue | $7.54M | $8.27M | $8.48M | $3.61M | $585K | $0 | $0 | $0 |
| Gross Profit | -$2.84M | -$3.92M | -$6.05M | -$3.24M | -$85K | $0 | $0 | $0 |
| Gross Margin | -60.3% | -90.2% | -249.2% | -858.6% | -17.0% | - | - | - |
| Research and Development | $5.68B | $5.99M | $7.25M | $11.47M | $9.3M | $5.44M | $3.46M | $716K |
| Selling, General, and Administrative | $41.58B | $36.62B | $35.66M | $39.82M | $18.04M | $2.84M | $959K | $615K |
| Other | -$47.21B | -$36.58B | -$478K | $1.65M | $0 | $0 | $278 | -$205K |
| Total Operating Expenses | $46.8M | $42.13M | $42.43M | $52.93M | $27.33M | $8.28M | $4.42M | $1.13M |
| Operating Income (EBIT) | -$49.64M | -$46.05M | -$48.48M | -$56.17M | -$27.42M | -$8.28M | -$4.42M | -$1.13M |
| Operating Margin | -1054.8% | -1059.6% | -1996.8% | -14899.5% | -5483.8% | - | - | - |
| Interest Expense | $22K | $26K | $416K | $8K | $659K | $0 | $0 | $0 |
| Interest Income | $386K | $322K | $424K | $88K | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$8.37M | $523K | -$4.18M | $0 | -$659K | $0 | $0 | $0 |
| Income Before Tax (EBT) | -$58.01M | -$45.53M | -$52.67M | -$56.17M | -$28.08M | -$8.28M | -$4.42M | -$1.13M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$58.01M | -$45.53M | -$52.67M | -$56.17M | -$28.08M | -$8.28M | -$4.42M | -$1.13M |
| Net Income Margin | -1232.7% | -1047.6% | -2169.1% | -14899.5% | -5615.6% | - | - | - |
| Supplementary Data | ||||||||
| EPS | -0.69 | -1.05 | -1.26 | -1.55 | -0.78 | -0.22 | -0.12 | -0.03 |
| Diluted EPS | -0.69 | -1.05 | -1.26 | -1.55 | -0.78 | -0.22 | -0.12 | -0.03 |
| Weighted Average OS | 101.95M | 50.52M | 41.76M | 36.17M | 36.06M | 36.99M | 36.99M | 36.99M |
| EBITDA | -$57.12M | -$44.34M | -$49.75M | -$54.23M | -$27.41M | $482 | -$456 | $563K |
| EBITDA Margin | -1213.7% | -1020.2% | -2049.1% | -14383.8% | -5483.0% | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $34.7M | $22.36M | $18.9M | $22.47M | $53.66M | $111K | $156K | $18K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $34.7M | $22.36M | $18.9M | $22.47M | $53.66M | $111K | $156K | $18K |
| Accounts Receivable | $643K | $405K | $45K | $17K | $200K | $0 | $0 | $0 |
| Inventory | $353K | $341K | $278K | $111K | $493K | $834K | $0 | $0 |
| Other Current Assets | $0 | $0 | $1.98M | $0 | $0 | $0 | $118K | $0 |
| Total Current Assets | $37.47M | $25.15M | $22.07M | $24.36M | $57.3M | $1.44M | $391K | $18K |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $2.62M | $3.7M | $2.64M | $3.6M | $971K | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $315K | $736K | $1.42M | $3.44M | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $47K | $1.13M | $1.13M | $1.11M | $725K | $755K | $643K | $0 |
| Total Long-Term Assets | $2.98M | $5.57M | $5.2M | $8.15M | $1.7M | $755K | $643K | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $40.45M | $30.71M | $27.27M | $32.51M | $59M | $2.19M | $1.03M | $18K |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $970K | $1.24M | $1.15M | $1.06M | $1.49M | $2.06M | $799K | $497K |
| Short-Term Debt | $24M | $18.6M | $13.95M | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $936K | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $2.04M | $1.35M | $791K | $879K | $557K | $0 | $5.32M | $583K |
| Total Current Liabilities | $28.58M | $23.52M | $29.38M | $8.43M | $4.26M | $15.71M | $6.34M | $1.08M |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $927K | $1.8M | $199K | $1.04M | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $29.51M | $25.32M | $29.58M | $9.46M | $4.26M | $15.71M | $6.34M | $1.08M |
| Stockholders' Equity | ||||||||
| Preferred Stock | $54.27M | $54.42M | $18.63M | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $131K | $63K | $42K | $41K | $35K | $14K | $14K | $10K |
| Retained Earnings | -$274.33M | -$203.77M | -$150.74M | -$98.08M | -$41.9M | -$13.83M | -$5.55M | -$1.13M |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $285.14M | $209.09M | $148.39M | $121.08M | $96.61M | $294K | $223K | $53K |
| Total Equity | $10.94M | $5.39M | -$2.31M | $23.05M | $54.74M | -$13.52M | -$5.31M | -$1.06M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $40.45M | $30.71M | $27.27M | $32.51M | $59M | $2.19M | $1.03M | $18K |
| Supplementary Data | ||||||||
| Total Debt | $25.82M | $21.25M | $15.26M | $2M | $0 | $0 | $0 | $0 |
| Net Debt | -$8.88M | -$1.1M | -$3.64M | -$20.48M | -$53.66M | -$111K | -$156K | -$18K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Operating Activities | ||||||||
| Net Income | -$58.01M | -$45.53M | -$52.67M | -$56.17M | -$28.08M | -$8.28M | -$4.42M | -$1.13M |
| Depreciation & Amortization | $872K | $1.17M | $2.5M | $1.94M | $4K | $8.28M | $4.42M | $1.69M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $4.49M | $4.53M | $6.82M | $14.99M | $9.6M | $65K | $174K | $80K |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | -$601K | $0 | -$28K | $183K | -$200K | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$270K | $96K | $89K | -$445K | -$665K | $1.15M | $302K | $497K |
| Other Working Capital | -$1.94M | -$4.53M | $5.61M | $9.17M | $1.67M | $1.44M | $1.58M | $223K |
| Total Working Capital Change | -$2.81M | -$4.43M | $5.67M | $8.91M | $807K | $2.59M | $1.89M | $720K |
| Other Non-Cash Items | $8.97M | $119K | $4.85M | $653K | $0 | -$8.28M | -$4.42M | -$1.53M |
| Net Cash from Operating | -$46.48M | -$44.14M | -$32.82M | -$29.68M | -$17.67M | -$5.63M | -$2.36M | -$171K |
| Investing Activities | ||||||||
| Capital Expenditures | -$197K | -$296K | -$221K | -$908K | -$862K | $0 | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | -$350K | $0 | -$3.2M | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$197K | -$646K | -$221K | -$4.11M | -$862K | $0 | $0 | $0 |
| Financing Activities | ||||||||
| Debt Repaid | - | - | -$10M | - | - | - | - | - |
| Common Stock Issuance | $58.67M | $451K | $284K | $1.81M | $70M | $5.58M | $2.5M | $132K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $551K | $804K | $2.08M | $0 | $0 | $132K |
| Net Cash from Financing | $59.03M | $48.25M | $29.46M | $2.61M | $72.08M | $5.58M | $2.5M | $132K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $12.35M | $3.46M | -$3.58M | -$31.18M | $53.55M | -$45K | $139K | $18K |
| Supplementary Data | ||||||||
| Operating Cash Flow | -$46.48M | -$44.14M | -$32.82M | -$29.68M | -$17.67M | -$5.63M | -$2.36M | -$114K |
| Capital Expenditure | -$197K | -$646K | -$221K | -$908K | -$862K | $0 | -$4 | $0 |
| Free Cash Flow | -$46.48M | -$44.79M | -$33.04M | -$30.59M | -$18.53M | -$5.63M | -$2.36M | -$114K |
| Cash at Beginning | $22.36M | $18.9M | $22.47M | $53.66M | $111K | $156K | $18K | $0 |
| Cash at End | $34.7M | $22.36M | $18.9M | $22.47M | $53.66M | $111K | $156K | $18K |